The content encompasses advances in the field of monoclonal antibodies, detailing their production process through hybridoma technology and their various applications in therapeutic treatments, particularly in oncology and immunotherapy. It highlights case studies and clinical evidences supporting their effectiveness in areas such as asthma management, inflammatory bowel disease, and virus treatment. The collection also discusses the mechanisms by which monoclonal antibodies interact with the immune system, their safety, and implications for patient care.
Embracing Progress, Transforming Treatment, Empowering Patients: Harnessing the Potential of TROP2-Targeted ADC Therapy in TNBC and HR+, HER2- Breast Cancer